| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $51.5M | +18.3% |
| Cost of Revenue | $4.5M | +3.0% |
| R&D Expense | $53.5M | +6.7% |
| SG&A Expense | $32.2M | +1.1% |
| Operating Income | -$78.7M | -0.8% |
| Interest Expense | $7.0M | +5.3% |
| Income Tax | $0 | — |
| Net Income | -$71.0M | -984.1% |
| EPS (Basic) | -$0.92 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $102.3M | -37.7% |
| Accounts Receivable | $21.3M | +0.9% |
| Inventory | $2.0M | +57.9% |
| Current Assets | $129.6M | -32.2% |
| Total Assets | $149.3M | -27.1% |
| Current Liabilities | $31.4M | +19.2% |
| Total Liabilities | $113.9M | -2.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.6M | +9.1% |
| Capital Expenditures | $3.7M | +211.1% |
| Investing Cash Flow | -$3.7M | -211.1% |
| Financing Cash Flow | $1.5M | -49.0% |
| Free Cash Flow | -$63.3M | +5.1% |
| -922.2% |
| EPS (Diluted) | -$0.97 | +1.0% |
| Stockholders' Equity |
| $35.4M |
| -59.8% |